Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Excelerate Health Ventures is a prominent venture capital fund based in the United States, dedicated to investing in early-stage companies within the healthcare sector. Founded by a team of experienced entrepreneurs, the firm focuses on leveraging artificial intelligence to innovate pharmaceutical technology and services. Excelerate Health Ventures aims to enhance healthcare outcomes while reducing costs, making it a key player in the evolving healthcare landscape. The firm primarily invests in pre-seed, seed, and Series A stages, providing crucial support to startups that are poised to make significant impacts in the healthcare industry.
While specific details regarding fund size and assets under management (AUM) are not disclosed, Excelerate Health Ventures has established a reputation for identifying high-potential startups. The firm’s investment strategy is informed by the interdisciplinary knowledge and experience of its team, which allows them to effectively evaluate and support innovative healthcare companies. Their commitment to improving patient outcomes through technology-enabled services positions them as a forward-thinking investor in the healthcare space.
Excelerate Health Ventures specializes in investing in AI-driven companies that are redefining the pharmaceutical industry. The firm emphasizes the development of healthcare software and technology-enabled services that enhance patient outcomes and reduce costs. Their investment focus includes sectors such as healthcare, artificial intelligence, and biotechnology, with a particular interest in startups that leverage technology to innovate traditional healthcare practices.
The firm seeks to partner with companies that are at the forefront of healthcare innovation, particularly those that utilize AI and machine learning to improve clinical trial processes, patient management, and overall healthcare delivery. Excelerate Health Ventures is particularly interested in startups that demonstrate a clear potential for scalability and impact within the healthcare ecosystem. By focusing on early-stage investments, the firm aims to provide not only capital but also strategic guidance to help these companies navigate the complexities of the healthcare market.
Excelerate Health Ventures boasts a diverse portfolio of innovative healthcare companies that have made significant strides in their respective fields. Notable investments include **Atalan**, which focuses on predicting and preventing turnover in health systems; **BEKHealth**, known for automating clinical trial feasibility and patient trial matching using AI/ML-enabled analytics; and **Censinet**, which offers a platform for vendor risk management tailored for healthcare providers. Other key portfolio companies include **Doctivity Health**, which enhances business development initiatives for healthcare providers, and **Elligo**, which accelerates clinical trials through a hybrid enrollment platform.
Several companies within Excelerate Health Ventures' portfolio have achieved successful exits, including **Bivarus**, **CarePort**, **Diameter Health**, and **NurseGrid**. These exits highlight the firm’s ability to identify and support high-potential startups that can deliver substantial returns on investment. The firm’s strategic focus on AI-driven healthcare solutions positions it well within a rapidly evolving industry, making its portfolio a testament to its investment acumen.
To pitch Excelerate Health Ventures, founders can submit their proposals through their website at exceleratehealth.com. The firm is open to both warm introductions and cold applications, so be sure to clearly outline your business model and how it aligns with their focus on AI-driven healthcare innovations.
Excelerate Health Ventures primarily invests in early-stage companies, focusing on pre-seed, seed, and Series A funding rounds. This allows them to support startups at critical points in their development.
The firm specializes in the healthcare sector, with a strong emphasis on companies that leverage artificial intelligence and biotechnology to innovate pharmaceutical technology and services.
While specific check sizes are not disclosed, Excelerate Health Ventures targets early-stage investments, which typically range from seed funding to Series A rounds, aligning with their focus on supporting startups in their formative stages.
Excelerate Health Ventures is based in the United States and primarily invests in companies located within the U.S. healthcare ecosystem.
Founders interested in pitching to Excelerate Health Ventures can submit their proposals through their website at exceleratehealth.com. The firm welcomes both warm introductions and cold applications.
Excelerate Health Ventures offers strategic guidance and mentorship to its portfolio companies, leveraging the team's extensive experience in the healthcare sector to help startups navigate challenges and scale effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.